An interventional study of Mindfulness Yoga and Time-Restricted Eating with nutritional counseling promoting a flexitarian dietary pattern in Alzheimer Disease, Aging and Lifestyle Factors, sponsored by St. Anne's University Hospital Brno, Czech Republic. Recruiting at 1 site in Czechia. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-06-27.
Sponsored by St. Anne's University Hospital Brno, Czech Republic · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 70 studies in Alzheimer Disease with a site in Czechia — 14 open to participants now, 18 under way, 8 of them phase 3. Alzheimer Disease · Czechia.
Among the 70 studies in Alzheimer Disease with a site in Czechia, this one is the 65th largest by planned enrollment of the 68 interventional ones that give a count, is one of 4 that started in 2024, is one of 6 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 65th registered.
3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.
Browse Alzheimer Disease studies →14 of the 70 studies in Alzheimer Disease with a site in Czechia are open now. Recruiting first, the newest first:
University Hospital, Akershus · Sites in Czechia
Ages 55–85
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Czechia, Australia, Austria and 14 more countries
Ages 18+
Exciva GmbH · Sites in Czechia, United States, Canada and 6 more countries
Ages 55–90
Bristol-Myers Squibb · Sites in Czechia, United States, Argentina and 23 more countries
Ages 55–90
MapLight Therapeutics · Sites in Czechia, United States, Argentina and 12 more countries
Ages 55–90
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.
This study: 60 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
70 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 27 · Phase 3 34
First in 2003; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 48 is below the median of 70 across 3,022 interventional studies indexed under Alzheimer Disease.
Median enrollment 434 across the 68 interventional studies, 25,542 across the 2 observational. Of the 51 that completed or were terminated, 25 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
64 of 70 have an industry lead sponsor. The 10 most frequent:
St. Anne's University Hospital Brno, Czech Republic is the lead sponsor of 25 studies on the registry; 9 are open to participants now.
St. Anne's University Hospital Brno, Czech Republic has 1 study filed under Alzheimer Disease — fewer than ten, so there is no comparison to draw.
2 of the studies in Alzheimer Disease with a site in Czechia that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05980949Phase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) | 2027-09-07 |
| NCT07042087St. Anne's University Hospital Brno, Czech RepublicLifestyle for the BRAin Health - Time Restricted Eating and Mindfulness | 2026-12 |
Add all 2 to your calendar (.ics) → With an account.
Among the 70 studies in Alzheimer Disease with a site in Czechia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study aims to evaluate the effects of a 9-month intervention combining yoga-based mindfulness techniques, cognitive training, and nutritional counseling on cognitive function, plasma markers of neurodegeneration (tau protein), physical fitness, and metabolism in older adults at increased risk of developing Alzheimer's disease.
This randomized two-arm clinical trial aims to evaluate the effects of a 9-month intervention combining yoga-based mindfulness techniques and time-restricted eating (Arm 1) versus cognitive training and stretching (Arm 2) in older adults at increased risk of developing Alzheimer's disease. The study will assess outcomes including cognitive function, plasma biomarkers of neurodegeneration (tau protein), physical fitness, and metabolic health.
The trial is harmonized with the concurrently running LIBRA-NET study (NCT06986096) conducted at Slovak sites (Bratislava and Banská Bystrica). Data from the cognitive training arm and additional clinical parameters will be pooled across both studies for joint statistical analyses. The studies share primary and several secondary outcomes, a shared intervention timeline, assessment protocols, and the cognitive training/stretching arm. The harmonization across all four study sites aims to increase statistical power and enable more generalizable conclusions for a larger population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will take part in a 9-month intervention consisting of yoga-based mindfulness sessions combined with time-restricted eating (16:8 protocol). The yoga program includes physical postures (asanas), breathing techniques, and meditation, aimed at improving physical fitness, stress regulation, and cognitive function. The dietary component promotes a flexitarian diet within an 8-hour daily eating window. Sessions are conducted twice weekly for 90 minutes under certified instructors.
Behavioral: Mindfulness Yoga · Behavioral: Time-Restricted Eating with nutritional counseling promoting a flexitarian dietary pattern
Participants in this arm will engage in a 9-month intervention including cognitive training exercises and guided stretching. The cognitive program targets multiple domains: verbal and non-verbal memory, executive functions, attention, language, and social cognition. Sessions are delivered twice weekly for 90 minutes by trained therapists. This intervention serves as an active comparator for assessing the effects of yoga and dietary modification on cognitive and biological outcomes.
Behavioral: Cognitive Training · Behavioral: Stretching
A structured 9-month program integrating physical yoga postures (asanas), breathing techniques, sound, and meditation. Sessions are conducted twice weekly (90 minutes each) and focus on enhancing physical health, stress regulation, and cognitive performance. Delivered by certified instructors.
Participants follow a 16:8 time-restricted eating schedule (16 hours fasting / 8 hours eating window) for 9 months, with nutritional counseling promoting a flexitarian dietary pattern. The intervention is designed to support metabolic health and reduce risk factors for neurodegeneration.
A 9-month structured program of twice-weekly cognitive training sessions (90 minutes each), targeting memory, attention, executive function, and social cognition using both paper-based and computer-based tasks. Supervised by trained therapists.
A twice-weekly stretching routine performed over 9 months (90-minute sessions), led by physiotherapists. This intervention provides low-intensity physical activity to control for physical engagement across study arms.
Composite Score of Cognitive Function
Change in composite neuropsychological score from baseline to post-intervention (9 months), including domain-specific scores for memory, executive function/attention, and psychomotor speed.
Time frame: Baseline and 9 months
Plasma Biomarkers of Neurodegeneration
Change in concentrations of plasma biomarkers: phosphorylated tau (pTau217, pTau181), GFAP, and neurofilament light chain (NfL).
Time frame: Baseline and 9 months
Computerized Cognitive Test Scores - Cogstate
Change in individual and composite scores on computerized cognitive tests (e.g., Cogstate), including measures of spatial orientation.
Time frame: Baseline and 9 months
Geriatric depression scale
Changes in depression, using the GDS scale
Time frame: Baseline and 9 months
Adherence to Intervention
Attendance rate and adherence to prescribed intervention protocol (minimum attendance threshold and dietary compliance).
Time frame: Throughout the 9-month intervention
Beck's anxiety inventory
Anxiety levels measured by the BAI
Time frame: Baseline and 9 months
Older People's Quality of Life Questionnaire scores
Quality of life measured by OPQOL-35
Time frame: Time Frame: Baseline and 9 months
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 25 months after the start.
Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 25 months is below that.
Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
St. Anne's University Hospital Brno, Czech Republic